The Laboratory for Cell Analysis (LCA) is a core facility that provides support to the UCSF ComprehensiveCancer Center. The LCA provides: Flow and image cytometers and the technical support needed to make use of these instruments. Education for UCSF students, staff and faculty in cytometry technology and applications. Expertise for the development of new cytometric assays.Instruments currently available to Cancer Center Members include: a Becton-Dickinson (BD) FACSVantageSE sorter with high-speed cell sorting, three laser excitation, ten detectors, and single-cell cloning; two BDFACSAria Digital cell sorters, three laser excitation, 15 detectors; four BD FACSCalibur flow cytometers withdual lasers capable of four-color analysis, automated sample loading and sorting options; fourZeissConfocal Laser Scanning Microscopes, three with multiphoton lasers, two with spectral emission detectionand live cell scanning capability; two digital video fluorescent microscopes; and two fluorescent microscopeswith high-resolution CCD cameras; a Cellomics ArrayScan HCS automated fluorescence microscopicimaging system for high-content screening and high-content analysis; and a Leica Laser Micro Dissectionmicroscope consisting of an automated upright microscope with a three-dimensional optical control of thedissection laser beam which uses noncontact sample collection by gravity. A variety of computer softwarepackages.and platforms are available to collect and analyze data. In addition, the staff of the LCA offers itsexpertise in the use of this technology as it applies to instrument support and biological applications toCancer Center Members. The LCA Web site is http://cancer.ucsf.edu/lca/index.php.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-09
Application #
7506480
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-09-25
Project End
2012-05-31
Budget Start
2007-09-25
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$272,252
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794
Olshen, Adam; Wolf, Denise; Jones, Ella F et al. (2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham) 5:011014
Li, Megan; Kroetz, Deanna L (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 182:152-160
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u
Cobler, Lara; Zhang, Hui; Suri, Poojan et al. (2018) xCT inhibition sensitizes tumors to ?-radiation via glutathione reduction. Oncotarget 9:32280-32297
Li, Megan; Mulkey, Flora; Jiang, Chen et al. (2018) Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 24:4734-4744

Showing the most recent 10 out of 192 publications